| Marcia Angela Bolles, PA-C | |
|
5249 E Terrace Dr, Madison, WI 53718-8339 | |
| (608) 222-9777 | |
| (608) 221-2646 |
| Full Name | Marcia Angela Bolles |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 13 Years |
| Location | 5249 E Terrace Dr, Madison, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003198029 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 2804-023 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Wi Hospitals & Clinics Authority | Madison, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Group Health Cooperative Of South Central Wisconsin | 3870489586 | 179 |
News Archive
The first test in humans of a bioartificial kidney offers hope of the device's potential to save the lives of people with acute renal failure, researchers at the University of Michigan Health System report.
Women who receive palbociclib (Ibrance) to treat their advanced breast cancer and have a gene alteration that can lead to a condition known as benign ethnic neutropenia (BEN), can safely receive the drug without major concerns of developing infections associated with neutropenia, or low white blood cell counts, say Georgetown Lombardi Comprehensive Cancer Center researchers.
In 2017 and 2019, the German Institute for Quality and Efficiency in Health Care had already examined the advantages and disadvantages of ribociclib in combination with an aromatase inhibitor or fulvestrant in comparison with the appropriate comparator therapy in patients after menopause, with hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.
One in every 100 elderly people suffers from Parkinson's disease, a disease of the nervous system with symptoms including stiffness and shaking. The standard medication used to treat Parkinson's is Levodopa, a drug that initially has major benefits but can later also produce serious side effects in the form of involuntary, jerky movements. A research group at Lund University has now found a way to study what it is in the brain that causes these side effects.
While clinical trial results are being released regarding drugs intended to decrease amyloid production - thought to contribute to decline in Alzheimer's disease - clinical trials of drugs targeting other disease proteins, such as tau, are in their initial phases.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marcia Angela Bolles, PA-C 7954 W Oakbrook Cir, Madison, WI 53717-1676 Ph: (608) 833-5609 | Marcia Angela Bolles, PA-C 5249 E Terrace Dr, Madison, WI 53718-8339 Ph: (608) 222-9777 |
News Archive
The first test in humans of a bioartificial kidney offers hope of the device's potential to save the lives of people with acute renal failure, researchers at the University of Michigan Health System report.
Women who receive palbociclib (Ibrance) to treat their advanced breast cancer and have a gene alteration that can lead to a condition known as benign ethnic neutropenia (BEN), can safely receive the drug without major concerns of developing infections associated with neutropenia, or low white blood cell counts, say Georgetown Lombardi Comprehensive Cancer Center researchers.
In 2017 and 2019, the German Institute for Quality and Efficiency in Health Care had already examined the advantages and disadvantages of ribociclib in combination with an aromatase inhibitor or fulvestrant in comparison with the appropriate comparator therapy in patients after menopause, with hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.
One in every 100 elderly people suffers from Parkinson's disease, a disease of the nervous system with symptoms including stiffness and shaking. The standard medication used to treat Parkinson's is Levodopa, a drug that initially has major benefits but can later also produce serious side effects in the form of involuntary, jerky movements. A research group at Lund University has now found a way to study what it is in the brain that causes these side effects.
While clinical trial results are being released regarding drugs intended to decrease amyloid production - thought to contribute to decline in Alzheimer's disease - clinical trials of drugs targeting other disease proteins, such as tau, are in their initial phases.
› Verified 9 days ago
Elise Kreger, Physician Assistant Medicare: Medicare Enrolled Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-1690 | |
Jeremi Thomas Olson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, Dean St. Mary's Outpatient Center, Madison, WI 53715 Phone: 608-260-2900 Fax: 608-260-7975 | |
Timothy J Morton, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 700 S Park St, Dean Medical Center, Madison, WI 53715 Phone: 608-251-6100 | |
Susan R Wilhelm, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 202 S Park St, Meriter Atrium, Madison, WI 53715 Phone: 608-417-5970 Fax: 608-417-5966 | |
Mrs. Teresa Lynn Wolfe, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 451 Junction Rd, Madison, WI 53717 Phone: 608-265-7670 Fax: 608-265-7739 | |
Erin M Mullan-towns, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, Madison, WI 53715 Phone: 608-260-2900 Fax: 608-260-2951 |